Brief Summary
Type:
Hematologic - Other
Study Type:
Prevention
Phase:
III
ClinicalTrials.gov Identifier:
NCT05711667
Study #:
CMH - ACCL1932
Start Date:
Oct 14, 2024
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT05711667
View Complete Trial Details & Eligibility at ClinicalTrials.gov
